Cronos Group Inc.
TSX:CRON.TODrug Manufacturers - Specialty & Generic
-$0.01 today
- Market cap
- $1.67B
- Beta
- 1.25
- P/E (TTM)
- -488.1
- EPS (TTM)
- -$0.01
Volume 0.15M
Average 0.19M
CRON.TO Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Cronos Group Inc.TSX: CRON.TO
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue growth accelerates
Q1 FY2026 cost of revenue of $26.05M rose 36.5% year over year, ahead of the +8.1% change in trailing-twelve-month cost of revenue. Sequentially, it fell 10.8% from the prior quarter. Over 3 fiscal years it compounded at +6.7% a year.
Context
- Cost of revenue amounted to 58.6% of revenue in FY2025, down 15.5 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +36.5% holds above the trailing-twelve-month pace of +8.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 87.45M USD
- Year-over-year change
- +0.5%
- 4-year CAGR
- +1.8%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 87.45M | +0.5% |
| FY2024 | 2024-12-31 | 87.05M | +15.8% |
| FY2023 | 2023-12-31 | 75.15M | +4.4% |
| FY2022 | 2022-12-31 | 71.96M | -11.7% |
| FY2021 | 2021-12-31 | 81.47M | — |
Cost of Revenue vs competitors
How CRON.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +8.1% is the 4th highest of 6, against a peer median of +19.7%.
- Cost of revenue amounts to 57.8% of revenue for CRON.TO, versus a peer median of 63.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | CA$1.2B CAD | -9.7% | +8.5% | 60.5% | |
| LTM Sep 2026 | CA$954.54M CAD | +19.7% | +14.2% | 85.9% | |
| LTM Mar 2026 | CA$929.1M CAD | +49.5% | +48.8% | 63.0% | |
| LTM Feb 2026 | $620.72M USD | +5.1% | +4.3% | 72.3% | |
| LTM Mar 2026 | CA$319.93M CAD | +55.9% | +24.4% | 62.7% | |
| LTM Mar 2026 | $92.19M USD | +8.1% | +6.7% | 57.8% | |
| Peer median (excluding CRON.TO) | — | +19.7% | +14.2% | 63.0% | |
Competitors are the stored peer set for CRON.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 64.02M | 87.54M | 87.03M | 117.5M | 149.15M |
| Cost of Revenue | 81.47M | 71.96M | 75.15M | 87.05M | 87.45M |
| Gross Profit | (17.45M) | 15.58M | 11.88M | 30.45M | 61.7M |
| Gross Margin | -27.3% | 17.8% | 13.7% | 25.9% | 41.4% |
| Research & Development | 21.66M | 13.25M | 5.83M | 4.22M | 4.53M |
| Selling, General & Admin | 120.67M | 101.64M | 80.74M | 76.74M | 75.01M |
| Operating Expenses | 272.09M | 128.01M | 96.48M | 106.91M | 79.54M |
| Depreciation & Amortization | 13.36M | 11.52M | 7.44M | 8.84M | 14.48M |
| EBITDA | (150.79M) | (93.81M) | (72.28M) | (45.37M) | (2.94M) |
| EBITDA Margin | -235.5% | -107.2% | -83.0% | -38.6% | -2.0% |
| Operating Income | (289.54M) | (112.44M) | (84.6M) | (76.46M) | (17.84M) |
| Operating Margin | -452.2% | -128.4% | -97.2% | -65.1% | -12.0% |
| Interest Income | 8.92M | 21.84M | 52.07M | 49.52M | 40.66M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 162.1M | (9.66M) | 11.1M | 113.01M | 419.21K |
| Income Before Tax | (127.44M) | (122.1M) | (73.49M) | 36.55M | (17.42M) |
| Pre-Tax Margin | -199.1% | -139.5% | -84.4% | 31.1% | -11.7% |
| Income Tax Expense | (427.41K) | 34.48M | (3.23M) | (3.44M) | (14.44M) |
| Net Income | (392.81M) | (170.26M) | (73.79M) | 41.04M | (9.61M) |
| Net Margin | -613.5% | -194.5% | -84.8% | 34.9% | -6.4% |
| EPS (Basic) | (0.34) | (0.42) | (0.18) | 0.10 | (0.03) |
| EPS (Diluted) | (0.34) | (0.42) | (0.18) | 0.10 | (0.03) |
| Weighted Avg Shares | 369.73M | 370.39M | 380.96M | 382.16M | 383.47M |
| Weighted Avg Shares (Diluted) | 370.39M | 370.39M | 380.96M | 382.16M | 383.47M |
Cronos Group Inc.
TSX:CRON.TO
Intrinsic Alpha fair value
Locked
Current Price
$4.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.